These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

680 related items for PubMed ID: 17906008

  • 1. Lowest effective transdermal 17beta-estradiol dose for relief of hot flushes in postmenopausal women: a randomized controlled trial.
    Bachmann GA, Schaefers M, Uddin A, Utian WH.
    Obstet Gynecol; 2007 Oct; 110(4):771-9. PubMed ID: 17906008
    [Abstract] [Full Text] [Related]

  • 2. Low dose of transdermal estradiol gel for treatment of symptomatic postmenopausal women: a randomized controlled trial.
    Simon JA, Bouchard C, Waldbaum A, Utian W, Zborowski J, Snabes MC.
    Obstet Gynecol; 2007 Mar; 109(3):588-96. PubMed ID: 17329509
    [Abstract] [Full Text] [Related]

  • 3. Estradiol in micellar nanoparticles: the efficacy and safety of a novel transdermal drug-delivery technology in the management of moderate to severe vasomotor symptoms.
    Simon JA, ESTRASORB Study Group.
    Menopause; 2006 Mar; 13(2):222-31. PubMed ID: 16645536
    [Abstract] [Full Text] [Related]

  • 4. Microdose transdermal estrogen therapy for relief of vulvovaginal symptoms in postmenopausal women.
    Bachmann GA, Schaefers M, Uddin A, Utian WH.
    Menopause; 2009 Mar; 16(5):877-82. PubMed ID: 19458560
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and tolerability of desvenlafaxine succinate treatment for menopausal vasomotor symptoms: a randomized controlled trial.
    Speroff L, Gass M, Constantine G, Olivier S, Study 315 Investigators.
    Obstet Gynecol; 2008 Jan; 111(1):77-87. PubMed ID: 18165395
    [Abstract] [Full Text] [Related]

  • 6. Micro-dose transdermal estradiol for relief of hot flushes in postmenopausal Asian women: a randomized controlled trial.
    Haines C, Yu SL, Hiemeyer F, Schaefers M.
    Climacteric; 2009 Oct; 12(5):419-26. PubMed ID: 19479489
    [Abstract] [Full Text] [Related]

  • 7. Low-dose estradiol spray to treat vasomotor symptoms: a randomized controlled trial.
    Buster JE, Koltun WD, Pascual ML, Day WW, Peterson C.
    Obstet Gynecol; 2008 Jun; 111(6):1343-51. PubMed ID: 18515518
    [Abstract] [Full Text] [Related]

  • 8. Percutaneous 17beta-estradiol gel for the treatment of vasomotor symptoms in postmenopausal women.
    Archer DF, EstroGel Study Group.
    Menopause; 2003 Jun; 10(6):516-21. PubMed ID: 14627859
    [Abstract] [Full Text] [Related]

  • 9. [Evaluation the efficacy and safety of estradiol and drospirenone tablets in the treatment of menopausal symptoms among postmenopausal Chinese healthy women:a randomized, multi-center, double-blind, placebo-controlled clinical study].
    Zhou YZ, Sun LZ, Lin JF, Yang X, Zhang LJ, Qiao J, Wang ZH, Xu YX, Xiong ZA, Lin SQ.
    Zhonghua Fu Chan Ke Za Zhi; 2011 May; 46(5):345-9. PubMed ID: 21733370
    [Abstract] [Full Text] [Related]

  • 10. Transition from estrogen-progestin to raloxifene in postmenopausal women: effect on vasomotor symptoms.
    Gordon S, Walsh BW, Ciaccia AV, Siddhanti S, Rosen AS, Plouffe L.
    Obstet Gynecol; 2004 Feb; 103(2):267-73. PubMed ID: 14754694
    [Abstract] [Full Text] [Related]

  • 11. A multicenter, prospective, randomized, double-blind, placebo-controlled study to investigate the efficacy of a continuous-combined hormone therapy preparation containing 1mg estradiol valerate/2mg dienogest on hot flushes in postmenopausal women.
    Endrikat J, Graeser T, Mellinger U, Ertan K, Holz C.
    Maturitas; 2007 Oct 20; 58(2):201-7. PubMed ID: 17889463
    [Abstract] [Full Text] [Related]

  • 12. A 12-week clinical trial determining the efficacy of synthetic conjugated estrogens, A (SCE), in the treatment of vasomotor symptoms in menopausal women.
    Stevens RE, Hanford K, Wason S, Cusack SL, Phelps KV.
    Int J Fertil Womens Med; 2000 Oct 20; 45(4):264-72. PubMed ID: 10997482
    [Abstract] [Full Text] [Related]

  • 13. A randomized, double-blind, placebo-controlled study of the lowest effective dose of drospirenone with 17β-estradiol for moderate to severe vasomotor symptoms in postmenopausal women.
    Archer DF, Schmelter T, Schaefers M, Gerlinger C, Gude K.
    Menopause; 2014 Mar 20; 21(3):227-35. PubMed ID: 23963307
    [Abstract] [Full Text] [Related]

  • 14. Low-dose estradiol for climacteric symptoms in Japanese women: a randomized, controlled trial.
    Honjo H, Taketani Y.
    Climacteric; 2009 Aug 20; 12(4):319-28. PubMed ID: 19330598
    [Abstract] [Full Text] [Related]

  • 15. Safety and efficacy of a continuous once-a-week 17beta-estradiol/levonorgestrel transdermal system and its effects on vasomotor symptoms and endometrial safety in postmenopausal women: the results of two multicenter, double-blind, randomized, controlled trials.
    Shulman LP, Yankov V, Uhl K.
    Menopause; 2002 Aug 20; 9(3):195-207. PubMed ID: 11973443
    [Abstract] [Full Text] [Related]

  • 16. A double-blind, randomly assigned, placebo-controlled study of desvenlafaxine efficacy and safety for the treatment of vasomotor symptoms associated with menopause.
    Archer DF, Seidman L, Constantine GD, Pickar JH, Olivier S.
    Am J Obstet Gynecol; 2009 Feb 20; 200(2):172.e1-10. PubMed ID: 19110224
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and tolerability of estradiol 1 mg and drospirenone 2 mg in postmenopausal Korean women: a double-blind, randomized, placebo-controlled, multicenter study.
    Lee BS, Kang BM, Yoon BK, Choi H, Park HM, Kim JG.
    Maturitas; 2007 Aug 20; 57(4):361-9. PubMed ID: 17467203
    [Abstract] [Full Text] [Related]

  • 18. Vasomotor hot flushes and 24-hour ambulatory blood pressure in normotensive women: A placebo-controlled trial on post-menopausal hormone therapy.
    Tuomikoski P, Haapalahti P, Sarna S, Ylikorkala O, Mikkola TS.
    Ann Med; 2010 Jul 20; 42(5):334-43. PubMed ID: 20429800
    [Abstract] [Full Text] [Related]

  • 19. Transdermal estradiol gel for the treatment of symptomatic postmenopausal women.
    Archer DF, Pickar JH, MacAllister DC, Warren MP.
    Menopause; 2012 Jun 20; 19(6):622-9. PubMed ID: 22282101
    [Abstract] [Full Text] [Related]

  • 20. Tibolone for the treatment of moderate to severe vasomotor symptoms and genital atrophy in postmenopausal women: a multicenter, randomized, double-blind, placebo-controlled study.
    Swanson SG, Drosman S, Helmond FA, Stathopoulos VM.
    Menopause; 2006 Jun 20; 13(6):917-25. PubMed ID: 17006377
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.